Frontier Biotechnologies Inc.SSE: 688221

Earnings Preannouncement for 2025

Jan 31, 2026 · Issued by Frontier Biotechnologies Inc. via Shanghai Stock Exchange

Filed with SSE · Jan 31, 2026

On 6ix: 6ix.com/news/earnings-preannouncement-for-2025-297

Earnings Preannouncement for 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment

6ix hasn’t read this filing yet.

Frontier Biotechnologies Inc. on 6ix

Earlier from Frontier Biotechnologies

Announcement on Completing Industrial and Commercial Change Registration for Company Address Change and Issuance of New Business LicenseJan 14
Announcement on Voluntary Disclosure of Acceptance Notice for the Clinical Trial Application for Domestic Production of Drugs of FB7013Jan 1
Announcement on Resolutions of the 9th Meeting of the 4th Board of DirectorsDec 12, 2025
Announcement on Election of Employee Directors for the 4th Board of DirectorsNov 20, 2025
Announcement on Convening the Q3 2025 Performance BriefingOct 31, 2025

Later from Frontier Biotechnologies

Announcement on the Signing of an Authorization and License Agreement with GSKFeb 24
Announcement on Preliminary Earnings Estimate for 2025Feb 28
Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of FB7013 InjectionMar 19
Announcement on Change of Scheduled Disclosure Time for Periodic ReportsMar 31
Announcement on Conducting Foreign Exchange Derivatives Trading BusinessApr 1

All Frontier Biotechnologies news releases

Follow Frontier Biotechnologies into a list and get an email when it puts out news.

Follow Frontier Biotechnologies